Cargando…
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction
BACKGROUND: Early withdrawal of recommended antiplatelet treatment with clopidogrel adversely affects prognosis following percutaneous coronary interventions. Optimal antiplatelet treatment is essential following ST‐segment elevation myocardial infarction (STEMI) given the increased risk of thrombot...
Autores principales: | Koskinas, Konstantinos C., Zanchin, Thomas, Klingenberg, Roland, Gencer, Baris, Temperli, Fabrice, Baumbach, Andreas, Roffi, Marco, Moschovitis, Aris, Muller, Oliver, Tüller, David, Stortecky, Stefan, Mach, Francois, Lüscher, Thomas F., Matter, Christian M., Pilgrim, Thomas, Heg, Dik, Windecker, Stephan, Räber, Lorenz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015438/ https://www.ncbi.nlm.nih.gov/pubmed/29654204 http://dx.doi.org/10.1161/JAHA.117.008085 |
Ejemplares similares
-
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome
por: Canivell, Silvia, et al.
Publicado: (2018) -
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
por: Gencer, Baris, et al.
Publicado: (2017) -
Post‐Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation
por: Koskinas, Konstantinos C., et al.
Publicado: (2016) -
Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience
por: Lanz, Jonas, et al.
Publicado: (2019) -
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
por: Carballo, David, et al.
Publicado: (2019)